Key result
CC-chemokine receptor inhibitor Met-RANTES reveals these receptors as potential therapeutic targets in Chagas disease.
Why the study?
The pathogenesis of Trypanosoma cruzi-elicited myocarditis and the role of CC-chemokines and their receptors in inflammation and heart dysfunction require further understanding to develop new therapeutic strategies.
Population
T. cruzi-infected mice
Comparison
CC-chemokine receptor inhibitor (Met-RANTES) vs no inhibitor
Design
Review discussing experimental results
Authors
Loading...
Supports CC-chemokine receptor targeting in Chagas disease; leaves open clinical translation from experimental models.
CC-chemokine receptors, specifically targeted by inhibitors like Met-RANTES, represent a potential therapeutic target for ameliorating inflammation in Trypanosoma cruzi-elicited myocarditis.
Marino et al. (2005) conducted a review in Trypanosoma cruzi-elicited myocarditis. CC-chemokine receptor inhibitor (Met-RANTES) was evaluated. A CC-chemokine receptor inhibitor (Met-RANTES) demonstrated the participation of CC-chemokines in T. cruzi infection, highlighting these receptors as potential therapeutic targets in Chagas disease.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: